BZP-49311-14657
5 vaccinations
9 coded responses
66 check-ins
8 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 154 / PA
- Registered
- 2021-02-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-10
Registered in v-safe
-
2021-02-10
Dose 1 — Moderna
- 2021-02-10
-
2021-02-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-24
- 2021-03-03
-
2021-03-10
Dose 2 — Moderna
- 2021-03-10
-
2021-03-11
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, NauseaFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-12
- 2021-03-13
-
2021-03-14
Survey response — days 1–6 daily, dose 2MedDRA: Injection site discomfort — Feeling: Good · Muscle or body achesFree text: mild discomfort in injection site-transiantMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-06-09
- 2021-09-08
-
2021-10-26
Dose 3 — Moderna
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fever · HeadacheAdult check-in
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fever · HeadacheAdult check-in
-
2021-10-30
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: Good · Site: Pain · Fever · HeadacheFree text: NoMedDRA releases: 2024-11 · check-in free text available
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-09
- 2021-11-17
- 2021-11-23
- 2021-11-30
- 2021-12-07
-
2022-01-25
Survey response — 3 months, dose 3MedDRA: Cough, Headache, Oropharyngeal pain — Feeling: GoodFree text: Sore throat(actually for about 5 or 6 days). Headaches same time for 5 or 6 days. Persistent cough(still have it).MedDRA releases: 2024-11 · check-in free text available
-
2022-04-08
Dose 4 — Moderna
- 2022-04-08
-
2022-04-09
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-04-10
- 2022-04-11
- 2022-04-12
- 2022-04-13
- 2022-04-14
- 2022-04-15
-
2022-04-22
Survey response — day 14, dose 4MedDRA: Injection site discomfort, Injection site pruritus — Feeling: GoodFree text: Increased itching at injection site along with more discomfort at site.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-29
- 2022-05-06
- 2022-05-13
- 2022-05-20
- 2022-07-08
- 2022-10-07
-
2022-10-09
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-10
Survey response — days 1–6 daily, dose 5MedDRA: No adverse event — Feeling: Fair · Site: Pain · HeadacheFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2022-10-11
Survey response — days 1–6 daily, dose 5MedDRA: Arthralgia, Headache — Feeling: Fair · Site: Redness · Headache, Joint painsFree text: Headache comes and goes. Joint pain just last night.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain, Redness, Itching · Headache, Joint painsAdult check-in
-
2022-10-13
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Redness, Itching · Headache, Muscle or body aches, DiarrheaAdult check-in
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-23
- 2022-10-30
-
2022-11-06
Survey response — day 28, dose 5MedDRA: Injection site pain, Pain — Feeling: GoodFree text: When using my arm on multiple occasions I get pain at injection site. This occurs only when exercising arm alot (racking leaves etc). Probably nothing. IDK.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-13
- 2022-11-20
-
2023-01-08
Survey response — 3 months, dose 5MedDRA: COVID-19, Dyspnoea, Gait disturbance, Influenza, Medical counselling, Respiratory disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-10 | Moderna | |
| 2 | 2021-03-10 | Moderna | |
| 3 | 2021-10-26 | Moderna | No |
| 4 | 2022-04-08 | Moderna | No |
| 5 | 2022-10-09 | Pfizer-BioNTech | Flu |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): No
Systemic reaction (other): mild discomfort in injection site-transiant
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): No
Release 11 — 3 months, dose 3
Symptoms: Sore throat(actually for about 5 or 6 days). Headaches same time for 5 or 6 days. Persistent cough(still have it).
Release 11 — day 14, dose 4
Symptoms: Increased itching at injection site along with more discomfort at site.
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): No
Systemic reaction (other): Headache comes and goes. Joint pain just last night.
Release 12 — day 28, dose 5
Symptoms: When using my arm on multiple occasions I get pain at injection site. This occurs only when exercising arm alot (racking leaves etc). Probably nothing. IDK.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Gait disturbance | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Injection site discomfort | · | · | ✓ |
| SD | Injection site pain | · | · | ✓ |
| SD | Injection site pruritus | · | · | ✓ |
| SD | Medical counselling | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SRO | Arthralgia | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Injection site discomfort | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release